MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 40391-40400 Newer>
The Motley Fool
February 23, 2010
Brian Orelli
The One That Didn't Get Away After some encouragement, the FDA approves Gilead's Cayston. mark for My Articles 746 similar articles
The Motley Fool
February 23, 2010
Anders Bylund
Brocade Ain't Broken! There's nothing wrong with data storage specialist Brocade that management can't fix themselves. mark for My Articles 159 similar articles
The Motley Fool
February 23, 2010
Brian Orelli
Triple-Teaming Cancer for Fun and Profit Pfizer, Merck and Eli Lilly set up a nonprofit, but there may be an ulterior motive. mark for My Articles 557 similar articles
The Motley Fool
February 23, 2010
Toby Shute
Huge Oil and Gas Reserves? Prove It! More companies come clean about their prized assets. mark for My Articles 100 similar articles
The Motley Fool
February 23, 2010
Morgan Housel
6 More Companies You Can Buy Today These stocks look cheap by this metric. The metric is simple, but seldom used: enterprise value over unlevered free cash flow. mark for My Articles 344 similar articles
The Motley Fool
February 23, 2010
Brian Orelli
The End of a Swine Flu Era A Food and Drug Administration advisory panel recommended yesterday that next year's seasonal flu vaccine contain the vaccine for the H1N1 virus, aka the swine flu. mark for My Articles 349 similar articles
The Motley Fool
February 23, 2010
Rick Aristotle Munarriz
3 Questions for Sirius XM Sirius XM is ready to report its quarterly results. mark for My Articles 1010 similar articles
The Motley Fool
February 23, 2010
Brian Orelli
Icahn Puts His Proxy Fight Where His Money Is How patient will Carl Icahn be with Genzyme's turnaround plan? That's the $270 million question -- the value of Icahn's shares, based on his holdings at the end of the year. mark for My Articles 192 similar articles
The Motley Fool
February 23, 2010
Rex Moore
This Stock Has Run Off Course Garmin was recommended originally because of its strong growth prospects in Europe and other international markets. But this is a stalling growth story, and there's too much optimism built into the five-year forecast of 11.4% annualized growth. mark for My Articles 190 similar articles
The Motley Fool
February 23, 2010
Rich Smith
6 Stocks That Never Surrender In a fight to the finish versus the S&P 500, no quarter will be asked, none given for defense industry stocks. mark for My Articles 488 similar articles
<Older 40391-40400 Newer>    Return to current articles.